All articles by
axsome therapeutics initiates focus phase 3 trial of solriamfetol for the treatment of attention deficit hyperactivity disorder (adhd) in adults
FOCUS is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of solriamfetol for the treatment of ADHD in adults
iWantGreatCare and Top Doctors merge to become the leading company for patient reviews in the healthcare sector
The goal is to become the reference company for reviews of doctors, clinics, and hospitals in the UK, to bring the best technology to the entire healthcare ecosystem, public and private
Novavax’s Nuvaxovid gets full marketing authorisation in EU for Covid prevention
The approval was based on the positive opinion for full marketing authorisation from the Committee for Medicinal Products for Human Use of the European Medicines Agency
Caribou Biosciences receives $25m equity investment from Pfizer
Pfizer has acquired around 4.7 million Caribou common shares at a price of $5.33 per share, pursuant to the terms of a Securities Purchase Agreement dated 29 June 2023
Thermo Fisher to acquire data intelligence company CorEvitas for $913m
CorEvitas offers regulatory-grade, real-world evidence solutions to biotechnology and pharmaceutical companies with objective data and clinical insights in order to enhance patient care and clinical outcomes
Inovedis secures US FDA approval for SINEFIX implant system for rotator cuff repair
The SINEFIX implant system introduces a simplified surgical technique specifically tailored for minimally invasive procedures, enabling efficient reattachment of the rotator cuff tendon to the bone
Bausch + Lomb Expands OTC Product Line with Acquisition of Blink Eye Drops
The strategic acquisition is the latest example of the company’s commitment to increasing over-the-counter (OTC) consumer convenience in eye care
Phasing out of extraordinary COVID-19 regulatory flexibilities
The extraordinary regulatory flexibilities covered different areas, including marketing authorisation and related regulatory procedures, manufacturing and importation of active pharmaceutical ingredients and finished products, quality variations, labelling and packaging requirements and compliance
Solenis wraps up acquisition of Diversey for $4.6bn
Diversey is a provider of hygiene, infection prevention and cleaning products and technology and will help develop cross-selling options that will make Solenis a valuable partner for its customers
NatureMetrics selects Sapio Science’s platform to accelerate environmental DNA monitoring
Sapio’s platform offers a comprehensive solution by integrating various lab informatics components, including a laboratory information management system (LIMS), an electronic laboratory notebook (ELN), and a scientific data management solution